BIOMAT Database Logo BIOMAT Database Logo

Uncompetitive NMDA receptor antagonists--is low affinity better? 2000

W Danysz, and T H Lanthorn

UI MeSH Term Description Entries
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D016194 Receptors, N-Methyl-D-Aspartate A class of ionotropic glutamate receptors characterized by affinity for N-methyl-D-aspartate. NMDA receptors have an allosteric binding site for glycine which must be occupied for the channel to open efficiently and a site within the channel itself to which magnesium ions bind in a voltage-dependent manner. The positive voltage dependence of channel conductance and the high permeability of the conducting channel to calcium ions (as well as to monovalent cations) are important in excitotoxicity and neuronal plasticity. N-Methyl-D-Aspartate Receptor,N-Methyl-D-Aspartate Receptors,NMDA Receptor,NMDA Receptor-Ionophore Complex,NMDA Receptors,Receptors, NMDA,N-Methylaspartate Receptors,Receptors, N-Methylaspartate,N Methyl D Aspartate Receptor,N Methyl D Aspartate Receptors,N Methylaspartate Receptors,NMDA Receptor Ionophore Complex,Receptor, N-Methyl-D-Aspartate,Receptor, NMDA,Receptors, N Methyl D Aspartate,Receptors, N Methylaspartate
D018691 Excitatory Amino Acid Antagonists Drugs that bind to but do not activate excitatory amino acid receptors, thereby blocking the actions of agonists. Amino Acids, Excitatory, Antagonists,Excitatory Amino Acid Antagonist,Glutamate Antagonist,Glutamate Antagonists,Glutamate Receptor Antagonist,Amino Acid Antagonists, Excitatory,Antagonists, Excitatory Amino Acid,EAA Antagonists,Glutamate Receptor Antagonists,Antagonist, Glutamate,Antagonist, Glutamate Receptor,Antagonists, EAA,Antagonists, Glutamate,Antagonists, Glutamate Receptor,Receptor Antagonist, Glutamate,Receptor Antagonists, Glutamate

Related Publications

W Danysz, and T H Lanthorn
Dizocilpine-like discriminative stimulus effects of low-affinity uncompetitive NMDA antagonists.
January 1996, Neuropharmacology,
W Danysz, and T H Lanthorn
Behavioral effects and anticonvulsant efficacies of low-affinity, uncompetitive NMDA antagonists in mice.
October 1999, Psychopharmacology,
W Danysz, and T H Lanthorn
Low affinity channel blocking (uncompetitive) NMDA receptor antagonists as therapeutic agents--toward an understanding of their favorable tolerability.
January 2000, Amino acids,
W Danysz, and T H Lanthorn
[New therapeutic possibilities with low-affinity NMDA receptor antagonists].
January 1996, Der Nervenarzt,
W Danysz, and T H Lanthorn
Uncompetitive NMDA receptor antagonists attenuate NMDA-induced impairment of passive avoidance learning and LTP.
July 1997, Neuropharmacology,
W Danysz, and T H Lanthorn
Low-affinity NMDA receptor antagonists. The neuroprotective potential of ARL 15896AR.
October 1997, Annals of the New York Academy of Sciences,
W Danysz, and T H Lanthorn
Amino-alkyl-cyclohexanes as a novel class of uncompetitive NMDA receptor antagonists.
January 2002, Current pharmaceutical design,
W Danysz, and T H Lanthorn
Memantine and the amino-alkyl-cyclohexane MRZ 2/579 are moderate affinity uncompetitive NMDA receptor antagonists--in vitro characterisation.
January 2000, Amino acids,
W Danysz, and T H Lanthorn
Low affinity use-dependent NMDA receptor antagonists show promise for clinical development.
January 2000, Amino acids,
W Danysz, and T H Lanthorn
The antiparkinsonian drugs budipine and biperiden are use-dependent (uncompetitive) NMDA receptor antagonists.
October 1994, European journal of pharmacology,
Copied contents to your clipboard!